Rankings
▼
Calendar
AUPH Q1 2023 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
AUPH
Aurinia Pharmaceuticals Inc.
$2B
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$34M
+59.1% YoY
Gross Profit
$34M
98.8% margin
Operating Income
-$30M
-86.0% margin
Net Income
-$26M
-76.2% margin
EPS (Diluted)
$-0.18
QoQ Revenue Growth
+21.0%
Cash Flow
Operating Cash Flow
-$32M
Free Cash Flow
-$32M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$452M
Total Liabilities
$61M
Stockholders' Equity
$390M
Cash & Equivalents
$89M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$34M
$22M
+59.1%
Gross Profit
$34M
$21M
+59.1%
Operating Income
-$30M
-$38M
+21.9%
Net Income
-$26M
-$38M
+30.4%
Revenue Segments
Product
$34M
100%
License, Royalty and Collaboration Revenue
$72,000
0%
← FY 2023
All Quarters
Q2 2023 →